Search Results - "Kim, Amy H"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Optogenetic activation of amygdala projections to nucleus accumbens can arrest conditioned and unconditioned alcohol consummatory behavior by Millan, E. Zayra, Kim, H. Amy, Janak, Patricia H.

    Published in Neuroscience (30-09-2017)
    “…•Optogenetic activation of basolateral amygdala (BLA) inputs to accumbens shell (AcbSh) reduced cue-induced alcohol seeking.•Optogenetic activation of BLA…”
    Get full text
    Journal Article
  2. 2

    Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress by Khasabova, Iryna A., Khasabov, Sergey G., Olson, Julie K., Uhelski, Megan L., Kim, Amy H., Albino-Ramírez, Alejandra M., Wagner, Chad L., Seybold, Virginia S., Simone, Donald A.

    Published in Pain (Amsterdam) (01-03-2019)
    “…Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a murine model of cisplatin-induced hyperalgesia, we determined…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation by Kim, Amy H., Tse, John C., Ikeda, Alan, Moore, Theodore B.

    Published in Pediatric transplantation (01-12-2009)
    “…:  BU is a commonly used conditioning agent in BMT. However, it is a narrow therapeutic index drug which shows a strong correlation between AUC and both…”
    Get full text
    Journal Article
  5. 5

    A Tale of Two Cities: COVID-19 and the Emotional Well-Being of Student-Athletes Using Natural Language Processing by Floyd, Carter, Gulavani, Susmit S., Du, James, Kim, Amy C. H., Pappas, Jason

    Published in Frontiers in sports and active living (25-08-2021)
    “…Student-athletes at the Division I institutions face a slew of challenges and stressors that can have negative impacts in eliciting different emotional…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Induction of Hepatic 8-Oxo-deoxyguanosine Adducts by 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Sprague−Dawley Rats Is Female-Specific and Estrogen-Dependent by Wyde, Michael E, Wong, Victoria A, Kim, Amy H, Lucier, George W, Walker, Nigel J

    Published in Chemical research in toxicology (01-07-2001)
    “…2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a hepatocarcinogen that induces sex-specific hepatic neoplastic alterations in female, but not male, rats. It has…”
    Get full text
    Journal Article
  9. 9

    Temporal trends of cardiac and respiratory responses to ventilatory challenges in congenital central hypoventilation syndrome by MACEY, Paul M, VALDERAMA, Claire, KIM, Amy H, WOO, Mary A, GOZAL, David, KEENS, Thomas G, HARPER, Rebecca K, HARPER, Ronald M

    Published in Pediatric research (01-06-2004)
    “…Congenital central hypoventilation syndrome (CCHS) patients exhibit respiratory deficits to ventilatory challenges, diminished breathing drive during sleep,…”
    Get full text
    Journal Article
  10. 10

    Physiological modeling of a proposed mechanism of enzyme induction by TCDD by Kohn, Michael C., Walker, Nigel J., Kim, Amy H., Portier, Christopher J.

    Published in Toxicology (Amsterdam) (21-05-2001)
    “…A physiological model was previously constructed to facilitate extrapolation of surrogates for the effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) in…”
    Get full text
    Journal Article
  11. 11

    Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo- p-dioxin exposure by Kim, Amy H, Kohn, Michael C, Nyska, Abraham, Walker, Nigel J

    Published in Toxicology and applied pharmacology (15-08-2003)
    “…An underlying basis of risk assessment is that an equivalent risk for a specified dose metric exists that allows for extrapolation of dose–response…”
    Get full text
    Journal Article
  12. 12

    Impact of Physiologically Based Pharmacokinetic Modeling on Benchmark Dose Calculations for TCDD-Induced Biochemical Responses by Kim, Amy H., Kohn, Michael C., Portier, Christopher J., Walker, Nigel J.

    Published in Regulatory toxicology and pharmacology (01-12-2002)
    “…In risk assessment, noncancer risk is currently estimated using a no observed adverse effect level (NOAEL) from an experimental dose–response study, divided by…”
    Get full text
    Journal Article
  13. 13

    Cardiac Responses to Pressor Challenges in Congenital Central Hypoventilation Syndrome by Kim, Amy H., Macey, Paul M., Woo, Mary A., Yu, Pearl L., Keens, Thomas G., Gozal, David, Ronald M. Harper, And

    “…Summary Question of the Study Congenital central hypoventilation syndrome (CCHS) subjects exhibit diminished respiratory‐related heart rate variation in…”
    Get full text
    Journal Article
  14. 14

    Role of Schwann Cell-Derived Exosomes in Cisplatin-Induced Hyperalgesia by Kim, Amy H

    Published 01-01-2018
    “…Painful peripheral neuropathy is a common dose-limiting side effect associated with cisplatin treatment. Cisplatin is unable to cross the blood-brain barrier,…”
    Get full text
    Dissertation
  15. 15

    To be or not to be: negotiating leisure constraints with technology and data analytics amid the COVID-19 pandemic by Du, James, Floyd, Carter, Kim, Amy C. H., Baker, Bradley J., Sato, Mikihiro, James, Jeffrey D., Funk, Daniel C.

    Published in Leisure studies (04-07-2021)
    “…The COVID-19 pandemic is having an unprecedented impact on the leisure industry. Mandatory directives such as social distancing and…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18